Table 1 The correlation between BRD9 level and clinicopathologic features of GIST patients.
Clinicopathologic features | BRD9 expression | p value | |
|---|---|---|---|
low (n = 19) | high (n = 19) | ||
Gender | |||
Male | 8 | 7 | 0.163 |
Female | 11 | 12 | |
Age | |||
≥60 | 7 | 9 | 0.278 |
<60 | 12 | 10 | |
Tumor site | |||
Stomach | 13 | 12 | 0.143 |
Intestinal | 6 | 7 | |
Tumor size (cm) | |||
<5 | 11 | 4 | 0.032 |
≥5 to <10 | 5 | 13 | |
≥10 | 3 | 2 | |
NIH criteria | |||
Low risk | 14 | 3 | 0.008 |
Intermediate risk | 3 | 3 | |
High risk | 2 | 13 | |
